Several Phase II clinical trials conducted by researchers from The University of Texas MD Anderson Cancer Center show promising results for patients with melanoma, breast cancer, HER2-positive tumors and ovarian cancer. The ...
May 24, 2021
0
1
In a collaborative report published today in Cell, scientists from Sydney and New York describe the critical worldwide need to improve the diversity of cells used in medical research. Currently, 95% of all human cell lines ...
May 13, 2021
0
3
A more than 30-year study into the long-term impact on mortality rates of screening for ovarian cancer has found that the cancer can be detected early and before women develop symptoms, but it does not translate to saving ...
May 13, 2021
0
2
A study published today in Nature Communications shows that the drug rucaparib has been effective in treating certain types of ovarian cancers if used early in treatment, after a diagnosis, and before the cancer cells build ...
May 4, 2021
0
32
(HealthDay)—For vulnerable older patients with ovarian cancer, single-agent carboplatin is less active, with worse survival, than combination carboplatin-paclitaxel regimens, according to a study published online April ...
Apr 27, 2021
0
2
A new study from University of Kentucky Markey Cancer researchers shows that Artemisia annua, a plant that has been traditionally used for its anti-malaria components, shows promise in treating ovarian cancer.
Apr 26, 2021
0
3
Modified immune cells that ruthlessly kill cancerous tumors may prove a game-changer for people living with late-stage cancer.
Apr 15, 2021
0
262
Ovarian cancer is a tough diagnosis to cope with, and now a new study finds these patients face a much higher risk of depression and other mental health issues.
Apr 12, 2021
0
12
Women undergoing surgery to treat stress urinary incontinence (SUI) are not at increased risk of developing pelvic cancers, according to a large-scale, population-based study in The Journal of Urology, Official Journal of ...
Apr 9, 2021
0
2
People with ovarian cancer frequently receive aggressive end-of-life care despite industry guidelines that emphasize quality of life for those with advanced disease, according to a recent study.
Apr 5, 2021
0
2
